OCA
ALPN
Octagon Capital Advisors’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,241,300
| Closed | -$49.2M | – | 58 |
|
|
2024
Q1 | $49.2M | Hold |
1,241,300
| – | – | 5.9% | 2 |
|
|
2023
Q4 | $23.7M | Buy |
1,241,300
+491,300
| +66% | +$9.36M | 3.79% | 9 |
|
|
2023
Q3 | $8.59M | Hold |
750,000
| – | – | 1.32% | 16 |
|
|
2023
Q2 | $7.71M | Sell |
750,000
-452,000
| -38% | -$4.65M | 1.07% | 19 |
|
|
2023
Q1 | $9.28M | Sell |
1,202,000
-23,000
| -2% | -$178K | 1.34% | 15 |
|
|
2022
Q4 | $9M | Hold |
1,225,000
| – | – | 1.4% | 16 |
|
|
2022
Q3 | $8.82M | Buy |
+1,225,000
| New | +$8.82M | 1.52% | 16 |
|